Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

Casanovas News&Views_v6_POST-PRINT.pdf (518.27 KB)

Document type

Article

Version

Accepted version

Publication date

2012-04-01

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/171689

Cancer: Limitations of therapies exposed

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1038/484044a

Abstract

Anti-angiogenic drugs, used for cancer treatment, target blood-vessel formation in tumours. Two studies commented here show that such drugs can reduce the efficiency of other anticancer agents and increase the aggressiveness of tumours.

Subject

Angiogènesi, Medicaments antineoplàstics, Tumors

Subject (English)

Neovascularization, Antineoplastic agents

Citation

Collections

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

CASANOVAS I CASANOVAS, Oriol. Cancer: Limitations of therapies exposed. Nature. 2012. Vol. 484, num. 7392, pags. 44-46. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/171689

Export metadata

JSON - METS

Share record